Atropine Sulfate 63323-0580-20
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Endotracheal, Intramedullary, Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 23, 2017
- Listing Expires
- December 31, 2026
- Application
- NDA209260
Need to source Atropine Sulfate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atropine Sulfate | .4 mg/mL |
Drug Class
Anticholinergic [EPC]Cholinergic Antagonists [MoA]Cholinergic Muscarinic Antagonist [EPC]
Selected Package
63323-0580-20Selected10 VIAL, MULTI-DOSE in 1 TRAY (63323-580-20) / 20 mL in 1 VIAL, MULTI-DOSE